Dantrolene Intravenous and Moxetumomab pasudotox
Determining the interaction of Dantrolene Intravenous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: Dantrolene
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrolene Intravenous-Moxetumomab Pasudotox-tdfk
- Dantrolene Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Dantrolene Intravenous-Moxifloxacin
- Dantrolene Intravenous-Moxifloxacin (Systemic)
- Dantrolene Intravenous-Moxifloxacin Hydrochloride
- Dantrolene Intravenous-Moxifloxacin Injection
- Moxetumomab pasudotox-Dantrolene Sodium
- Moxetumomab pasudotox-Dapagliflozin
- Moxetumomab pasudotox-Dapagliflozin and metformin
- Moxetumomab pasudotox-Dapagliflozin and Metformin Extended-Release Tablets
- Moxetumomab pasudotox-Dapagliflozin and saxagliptin
- Moxetumomab pasudotox-Dapagliflozin Propanediol